| Ausstehende Aktien | 11,374,360 shares |
| Insider-Aktien | 3.139.776 shares |
| Insider-Besitz | 27,60 % |
| Insider gesamt | 25 |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Prozent des Streubesitzes von Insidern gekauft (Rang)
2348 out of 10752
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
BG Medicine, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
|
Noubar Afeyan
Director, 10% Owner -
[D]
|
0 | 0 | |
| Charles H Jr Abdalian | 140.000 | ||
| Adourian Aram S. SVP & Chief Scientific Officer - [O] | 40.036 | 40.036 | |
| Harrison M Jr Bains | 4.205 | ||
| Stephane Bancel Executive Chairman, Director - [D] [O] | 123.167 | 30.792 | |
| Eric Bouvier President, CEO, Director - [D] [O] | 10.000 | 2.500 | |
| William Densel | 0 | ||
|
Flagship Ventures 2007 General Partner LLC
10% Owner -
|
882.142 | 882.142 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
|
Flagship Ventures Fund 2007, L.P.
10% Owner -
|
882.142 | 882.142 | |
| Neal Gordon | 30.000 | ||
|
Gilde Europe Food & Agribusiness Partners II C.V.
10% Owner -
|
1.635.432 | 408.858 | |
| Stephen P Hall EVP & Chief Financial Officer - [O] | 31.034 | 31.034 | |
| Harris Timothy J.R. | 4.205 | ||
| Jeffrey R Luber | 0 | ||
| Miller Stephen R. | 30.000 | ||
| Pieter Muntendam EVP, Chief Medical Officer - [O] | 78.483 | 19.621 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| James F O Oconnor | 0 | ||
| Stelios Papadopoulos Director - [D] | 1.187.713 | 296.928 | |
| Brian S Posner Director - [D] | 20.000 | 5.000 | |
| Michael W Rogers | 35.000 | ||
| Anastasia Rader | 42.000 | ||
| Paul R Sohmer President & CEO, Director - [D] [O] | 53.161 | 53.161 | |
| Haygood Paterson Sr Seawell - | 1.308.965 | 1.308.965 | |
| Harry W Wilcox | 5.000 | ||
|
der Meer Pieter van
10% Owner -
|
1.635.432 | 408.858 |
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in BGMD / BG Medicine, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in BGMD / BG Medicine, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-06-27 | 3 | Seawell Haygood Paterson Sr | BGMD | Common Stock | D | 2.587.930 | ||||||||
| 2016-06-27 | 3 | Seawell Haygood Paterson Sr Spouse | BGMD | Common Stock | I | 1.308.965 | ||||||||
| 2016-06-27 | 3 | Seawell Haygood Paterson Sr Spouse | BGMD | Common Stock | I | 1.308.965 | ||||||||
| 2016-06-27 | 3 | Seawell Haygood Paterson Sr | BGMD | Common Stock | D | 2.587.930 | ||||||||
| 2016-05-04 | 2014-04-14 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 0,90 | -12.000 | 16.036 | |||||
| 2016-05-04 | 2014-04-14 | 4 | Adourian Aram S. | BGMD | Common Stock | D | 0,9000 | 12.000 | 11 | 40.036 | ||||
| 2016-04-04 | 2016-03-31 | 4 | HALL STEPHEN P | BGMD | Common Stock | D | 0,3600 | -8.986 | -3 | 31.034 | ||||
| 2016-04-04 | 2016-03-31 | 4 | SOHMER PAUL R | BGMD | Common Stock | D | 0,3600 | -15.493 | -6 | 53.161 | ||||
| 2016-04-04 | 2016-03-31 | 4 | Adourian Aram S. | BGMD | Common Stock | D | 0,3600 | -7.456 | -3 | 35.770 | ||||
| 2016-02-05 | 2016-02-04 | 4 | LUBER JEFFREY R | BGMD | Stock option (right to buy) | D | 0,29 | 10.000 | 10.000 | |||||
| 2015-12-11 | 2015-12-09 | 4 | AFEYAN NOUBAR Held by Atlast LP | BGMD | Common Stock | I | 0,5600 | -2.508 | -1 | 0 | ||||
| 2015-12-11 | 2015-12-09 | 4 | AFEYAN NOUBAR | BGMD | Common Stock | D | 0,5600 | -43.930 | -25 | 0 | ||||
| 2015-11-20 | 2015-11-18 | 4 | PAPADOPOULOS STELIOS | BGMD | Stock Option (right to buy) | D | 0,52 | 5.000 | 5.000 | |||||
| 2015-11-20 | 2015-11-18 | 4 | AFEYAN NOUBAR | BGMD | Stock Option (right to buy) | D | 0,52 | 5.000 | 5.000 | |||||
| 2015-11-20 | 2015-11-18 | 4 | OCONNOR JAMES F O | BGMD | Stock Option (right to buy) | D | 0,52 | 12.500 | 12.500 | |||||
| 2015-11-20 | 2015-11-18 | 4 | WILCOX HARRY W | BGMD | Stock Option (right to buy) | D | 0,52 | 5.000 | 5.000 | |||||
| 2015-08-19 | 2015-08-15 | 4 | Adourian Aram S. | BGMD | Common Stock | D | 0,8300 | -6.233 | -5 | 40.226 | ||||
| 2015-08-19 | 2015-08-15 | 4 | SOHMER PAUL R | BGMD | Common Stock | D | 0,8300 | -13.321 | -11 | 68.654 | ||||
| 2015-08-19 | 2015-08-15 | 4 | HALL STEPHEN P | BGMD | Common Stock | D | 0,8300 | -7.505 | -6 | 39.995 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -8.410 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -4.205 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -4.205 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -4.205 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -4.205 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -53.857 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -530 | -1 | 786.970 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 8.410 | 1 | 787.500 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -265 | -1 | 779.090 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -265 | -1 | 779.090 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -265 | -1 | 779.090 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -265 | -1 | 779.090 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 4.205 | 1 | 779.355 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 4.205 | 1 | 779.355 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 4.205 | 1 | 779.355 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 4.205 | 1 | 779.355 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -3.390 | -8 | 763.330 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 53.857 | 8 | 766.720 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -508 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -254 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -254 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -254 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -254 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,14 | -3.256 | 0 | |||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -32 | -0 | 58.232 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 508 | 0 | 58.264 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -16 | -0 | 57.756 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -16 | -0 | 57.756 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -16 | -0 | 57.756 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -16 | -0 | 57.756 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 254 | 0 | 57.772 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 254 | 0 | 57.772 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 254 | 0 | 57.772 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 254 | 0 | 57.772 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,2700 | -206 | -0 | 56.804 | ||||
| 2015-07-29 | 2015-07-27 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 0,1400 | 3.256 | 0 | 57.010 | ||||
| 2015-07-16 | 3 | Flagship Ventures Fund 2007, L.P. Held by Flagship Ventures Fund 2007, L.P. | BGMD | Common Stock | I | 882.142 | ||||||||
| 2015-07-16 | 3 | Flagship Ventures Fund 2007, L.P. Held by Flagship Ventures Fund 2007, L.P. | BGMD | Common Stock | I | 882.142 | ||||||||
| 2015-07-16 | 3 | Flagship Ventures Fund 2007, L.P. Held by Flagship Ventures Fund 2007, L.P. | BGMD | Common Stock | I | 882.142 | ||||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. | BGMD | Series A Preferred Stock | I | 1,7003 | 397.072 | 675 | 497.729 | ||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. | BGMD | Series A Preferred Stock | I | 100.657 | 100.657 | ||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Flagship Ventures Fund 2007, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Series A Preferred Stock | I | 1,7003 | 53.465 | 91 | 67.018 | ||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Series A Preferred Stock | I | 13.553 | 13.553 | ||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by AGTC Advisors Fund, L.P. | BGMD | Secured Convertible Promissory Note | I | 1,70 | |||||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Series A Preferred Stock | I | 1,7003 | 725.725 | 1.234 | 909.696 | ||||
| 2015-07-16 | 2015-07-14 | 4 | AFEYAN NOUBAR Held by Applied Genomic Technology Capital Fund, L.P. | BGMD | Series A Preferred Stock | I | 183.971 | 183.971 | ||||||
| 2015-02-24 | 2015-02-20 | 4 | SOHMER PAUL R | BGMD | Stock Option (right to buy) | D | 0,82 | 200.000 | 200.000 | |||||
| 2015-02-24 | 2015-02-20 | 4 | HALL STEPHEN P | BGMD | Stock Option (right to buy) | D | 0,82 | 140.000 | 140.000 | |||||
| 2015-02-24 | 2015-02-20 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 0,82 | 140.000 | 140.000 | |||||
| 2014-12-11 | 2014-12-11 | 4 | KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. | BGMD | Common Stock | I | 0,3000 | -369.112 | -111 | 0 | ||||
| 2014-12-11 | 2014-12-11 | 4 | KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. | BGMD | Common Stock | I | 0,3000 | -18.468 | -6 | 0 | ||||
| 2014-12-11 | 2014-12-10 | 4 | KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. | BGMD | Common Stock | I | 0,3200 | -109.248 | -35 | 369.112 | ||||
| 2014-12-11 | 2014-12-10 | 4 | KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. | BGMD | Common Stock | I | 0,3200 | -5.472 | -2 | 18.468 | ||||
| 2014-12-11 | 2014-12-09 | 4 | KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. | BGMD | Common Stock | I | 0,3600 | -125.789 | -45 | 478.360 | ||||
| 2014-12-11 | 2014-12-09 | 4 | KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. | BGMD | Common Stock | I | 0,3600 | -6.301 | -2 | 23.940 | ||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR | BGMD | Common Stock | D | 11.190 | 0 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | -703.655 | 0 | ||||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -12.183 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -12.183 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -12.183 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -5.988 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,04 | -12.021 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,4600 | -440 | -0 | 703.655 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,4600 | -440 | -0 | 703.655 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,4600 | -440 | -0 | 703.655 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,0200 | 12.183 | 0 | 704.095 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,0200 | 12.183 | 0 | 704.095 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,0200 | 12.183 | 0 | 704.095 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,4600 | -216 | -0 | 668.426 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,0200 | 5.988 | 0 | 668.642 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,4600 | -927 | -0 | 662.654 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 0,0400 | 12.021 | 0 | 663.581 | ||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | -98.352 | 0 | ||||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.724 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.724 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.724 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -847 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,04 | -464 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.352 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.352 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.352 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,0200 | 1.724 | 0 | 98.415 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,0200 | 1.724 | 0 | 98.415 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,0200 | 1.724 | 0 | 98.415 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,4600 | -31 | -0 | 93.369 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,0200 | 847 | 0 | 93.400 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,4600 | -37 | -0 | 92.553 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by ST NewcoGen LLC | BGMD | Common Stock | I | 0,0400 | 464 | 0 | 92.590 | ||||
| 2014-12-05 | 2014-12-04 | 4 | KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. | BGMD | Common Stock | I | 592.959 | 604.149 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | KANIA EDWIN M JR Held by OneLiberty Fund IV, L.P. | BGMD | Common Stock | I | 11.190 | 11.190 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. | BGMD | Common Stock | I | 29.648 | 30.241 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | KANIA EDWIN M JR Held by OneLiberty Advisors Fund IV, L.P. | BGMD | Common Stock | I | 593 | 593 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | -98.570 | 0 | ||||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.729 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.729 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -1.729 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -850 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,04 | -499 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.570 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.570 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,4600 | -63 | -0 | 98.570 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,0200 | 1.729 | 0 | 98.633 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,0200 | 1.729 | 0 | 98.633 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,0200 | 1.729 | 0 | 98.633 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,4600 | -32 | -0 | 93.572 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,0200 | 850 | 0 | 93.604 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,4600 | -39 | -0 | 92.754 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen-Long Reign Holding LLC | BGMD | Common Stock | I | 0,0400 | 499 | 0 | 92.793 | ||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR Held by Atlast LP | BGMD | Common Stock | I | 10.029 | 10.029 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR | BGMD | Common Stock | D | 164.528 | 175.718 | ||||||
| 2014-12-05 | 2014-12-04 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | -2.484.192 | 0 | ||||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -17.080 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -17.080 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -17.080 | 0 | |||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,4600 | -616 | -0 | 2.484.192 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,4600 | -616 | -0 | 2.484.192 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,0200 | 17.080 | 0 | 2.484.808 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,0200 | 17.080 | 0 | 2.484.808 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,0200 | 17.080 | 0 | 2.484.808 | ||||
| 2014-12-05 | 2014-12-03 | 4 | AFEYAN NOUBAR Held by NewcoGen Group LLC | BGMD | Common Stock | I | 0,4600 | -616 | -0 | 7.298.474 | ||||
| 2014-10-17 | 2014-10-16 | 4 | SOHMER PAUL R | BGMD | Common Stock | D | 327.900 | 327.900 | ||||||
| 2014-10-17 | 2014-10-16 | 4 | HALL STEPHEN P | BGMD | Common Stock | D | 190.200 | 190.200 | ||||||
| 2014-10-17 | 2014-10-16 | 4 | Adourian Aram S. | BGMD | Common Stock | D | 157.800 | 185.836 | ||||||
| 2014-06-05 | 2014-06-03 | 4 | AFEYAN NOUBAR | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-06-05 | 2014-06-03 | 4 | BAINS HARRISON M JR | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-06-05 | 2014-06-03 | 4 | PAPADOPOULOS STELIOS | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-06-05 | 2014-06-03 | 4 | Posner Brian S | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-06-05 | 2014-06-03 | 4 | Harris Timothy J.R. | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-06-05 | 2014-06-03 | 4 | Bancel Stephane | BGMD | Stock Option (right to buy) | D | 1,00 | 4.205 | 4.205 | |||||
| 2014-02-06 | 2014-02-04 | 4 | SOHMER PAUL R | BGMD | Stock Option (right to buy) | D | 1,15 | 250.000 | 250.000 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 1,15 | 93.000 | 93.000 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 1,15 | 50.000 | 50.000 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Rader Anastasia | BGMD | Stock Option (right to buy) | D | 1,15 | 42.000 | 42.000 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Rader Anastasia | BGMD | Stock Option (right to buy) | D | 1,15 | 40.000 | 40.000 | |||||
| 2013-12-18 | 2013-12-17 | 4 | HALL STEPHEN P | BGMD | Stock Option (right to buy) | D | 0,89 | 150.000 | 150.000 | |||||
| 2013-11-04 | 2013-11-01 | 4 | Bancel Stephane | BGMD | Stock Option (right to buy) | D | 0,62 | 101.351 | 101.351 | |||||
| 2013-08-05 | 2013-08-01 | 4 | Bancel Stephane | BGMD | Stock Option (right to buy) | D | 1,20 | 52.083 | 52.083 | |||||
| 2013-06-14 | 2013-06-12 | 4 | Posner Brian S | BGMD | Stock Option (Right to Buy) | D | 1,68 | 4.205 | 4.205 | |||||
| 2013-06-14 | 2013-06-12 | 4 | PAPADOPOULOS STELIOS | BGMD | Stock Option (right to buy) | D | 1,68 | 4.205 | 4.205 | |||||
| 2013-06-14 | 2013-06-12 | 4 | AFEYAN NOUBAR | BGMD | Stock Option (right to buy) | D | 1,68 | 4.205 | 4.205 | |||||
| 2013-06-14 | 2013-06-12 | 4 | BAINS HARRISON M JR | BGMD | Stock Option (right to buy) | D | 1,68 | 4.205 | 4.205 | |||||
| 2013-06-14 | 2013-06-12 | 4 | Harris Timothy J.R. | BGMD | Stock Option (right to buy) | D | 1,68 | 4.205 | 4.205 | |||||
| 2013-05-14 | 2013-05-10 | 4 | SOHMER PAUL R | BGMD | Stock Options (right to buy) | D | 1,67 | 700.000 | 700.000 | |||||
| 2013-05-03 | 2013-05-01 | 4 | Bancel Stephane | BGMD | Stock Option (right to buy) | D | 1,61 | 39.473 | 39.473 | |||||
| 2013-04-30 | 2013-04-26 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 1,69 | 200.000 | 200.000 | |||||
| 2013-04-30 | 2013-04-26 | 4 | Rader Anastasia | BGMD | Stock Option (right to buy) | D | 1,69 | 75.000 | 75.000 | |||||
| 2013-02-01 | 2013-01-30 | 4 | PAPADOPOULOS STELIOS | BGMD | Common Stock | D | 2,0000 | 250.000 | 500 | 1.187.713 | ||||
| 2013-02-01 | 2013-01-30 | 4 | AFEYAN NOUBAR By Flagship Ventures Fund 2007, L.P. | BGMD | Common Stock | I | 2,0000 | 1.050.000 | 2.100 | 1.764.286 | ||||
| 2013-02-01 | 2013-01-30 | 4 | AFEYAN NOUBAR By Applied Genomic Technology Capital Fund, L.P. | BGMD | Common Stock | I | 2,0000 | 500.000 | 1.000 | 2.851.447 | ||||
| 2013-02-01 | 2013-01-30 | 4 | AFEYAN NOUBAR By AGTC Advisors Fund, L.P. | BGMD | Common Stock | I | 2,0000 | 75.000 | 150 | 215.013 | ||||
| 2013-02-01 | 2013-01-30 | 4 | AFEYAN NOUBAR By NewcoGen Equity Investors LLC | BGMD | Common Stock | I | 2,0000 | 125.000 | 250 | 651.560 | ||||
| 2013-02-01 | 2013-01-30 | 4 | AFEYAN NOUBAR By NewcoGen Group LLC | BGMD | Common Stock | I | 2,0000 | 250.000 | 500 | 2.434.800 | ||||
| 2012-12-12 | 2012-12-10 | 4 | Abdalian Charles H Jr | BGMD | Stock Option (right to buy) | D | 1,33 | 140.000 | 140.000 | |||||
| 2012-11-20 | 2012-11-19 | 4 | Posner Brian S | BGMD | Common Stock | D | 1,1650 | 10.000 | 12 | 20.000 | ||||
| 2012-11-19 | 2012-11-15 | 4 | Bancel Stephane | BGMD | Common Stock | D | 1,2600 | 100.000 | 126 | 123.167 | ||||
| 2012-10-09 | 2012-10-04 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 3,61 | 40.000 | 40.000 | |||||
| 2012-09-17 | 2012-09-13 | 4 | Bancel Stephane | BGMD | Common Stock | D | 3,7000 | 1.381 | 5 | 23.167 | ||||
| 2012-08-22 | 2012-08-21 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | -298.137 | 0 | ||||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -6.422 | 0 | |||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -6.422 | 0 | |||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -6.422 | 0 | |||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,03 | -2.353 | 0 | |||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 5,8300 | -23 | -0 | 298.137 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 5,8300 | -23 | -0 | 298.137 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 0,0200 | 6.422 | 0 | 298.160 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 0,0200 | 6.422 | 0 | 298.160 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 5,8300 | -23 | -0 | 285.339 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 0,0200 | 6.422 | 0 | 285.362 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 5,8300 | -13 | -0 | 278.940 | ||||
| 2012-08-22 | 2012-08-20 | 4 | AFEYAN NOUBAR By NewcoGen-Elan LLC | BGMD | Common Stock | I | 0,0300 | 2.353 | 0 | 278.953 | ||||
| 2012-08-10 | 2012-08-08 | 4 | Densel William | BGMD | Stock Option (right to buy) | D | 6,90 | 100.000 | 100.000 | |||||
| 2012-06-13 | 2012-06-11 | 4 | AFEYAN NOUBAR | BGMD | Stock Option (right to buy) | D | 5,69 | 4.205 | 4.205 | |||||
| 2012-06-13 | 2012-06-11 | 4 | BAINS HARRISON M JR | BGMD | Stock Option (right to buy) | D | 5,69 | 4.205 | 4.205 | |||||
| 2012-06-13 | 2012-06-11 | 4 | PAPADOPOULOS STELIOS | BGMD | Stock Option (right to buy) | D | 5,69 | 4.205 | 4.205 | |||||
| 2012-06-13 | 2012-06-11 | 4 | Harris Timothy J.R. | BGMD | Stock Option (right to buy) | D | 5,69 | 4.205 | 4.205 | |||||
| 2012-06-11 | 2012-06-08 | 4 | Muntendam Pieter | BGMD | Common Stock | D | 5,2900 | -3.965 | -21 | 78.483 | ||||
| 2012-06-11 | 2012-06-07 | 4 | Muntendam Pieter | BGMD | Common Stock | D | 5,5000 | -30.021 | -165 | 82.448 | ||||
| 2012-06-01 | 2012-05-30 | 4 | Muntendam Pieter | BGMD | Stock Option (right to buy) | D | 0,90 | -100.000 | 82.239 | |||||
| 2012-06-01 | 2012-05-30 | 4 | Muntendam Pieter | BGMD | Common Stock | D | 0,9000 | 100.000 | 90 | 112.469 | ||||
| 2012-05-24 | 2012-05-23 | 4 | Bouvier Eric | BGMD | Common Stock | D | 3,9500 | 10.000 | 40 | 10.000 | ||||
| 2012-05-23 | 2012-05-23 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | -130.867 | 0 | ||||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -7.001 | 0 | |||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -7.001 | 0 | |||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -7.001 | 0 | |||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,02 | -2.580 | 0 | |||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Warrant to Purchase Common Stock (right to buy) | I | 0,03 | -2.497 | 0 | |||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 3,9500 | -36 | -0 | 130.867 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 3,9500 | -36 | -0 | 130.867 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 3,9500 | -36 | -0 | 130.867 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 0,0200 | 7.001 | 0 | 130.903 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 0,0200 | 7.001 | 0 | 130.903 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 0,0200 | 7.001 | 0 | 130.903 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 3,9500 | -14 | -0 | 109.972 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 0,0200 | 2.580 | 0 | 109.986 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 3,9500 | -19 | -0 | 107.406 | ||||
| 2012-05-23 | 2012-05-21 | 4 | AFEYAN NOUBAR By NewcoGen-PE LLC | BGMD | Common Stock | I | 0,0300 | 2.497 | 0 | 107.425 | ||||
| 2012-05-23 | 2012-05-22 | 4 | Posner Brian S | BGMD | Common Stock | D | 4,0400 | 10.000 | 40 | 10.000 | ||||
| 2012-05-21 | 2012-05-17 | 4 | Bancel Stephane | BGMD | Common Stock | D | 3,8400 | 5.008 | 19 | 21.786 | ||||
| 2012-04-19 | 2012-04-17 | 4 | van der Meer Pieter By Gilde Europe Food & Agribusiness Fund B.V. | BGMD | Common Stock | I | 6,6000 | -200.000 | -1.320 | 1.635.432 | ||||
| 2012-03-21 | 2012-03-19 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 0,90 | -7.009 | 0 | |||||
| 2012-03-21 | 2012-03-19 | 4 | Adourian Aram S. | BGMD | Common Stock | D | 0,9000 | 7.009 | 6 | 28.036 | ||||
| 2012-02-29 | 2012-02-27 | 4 | AFEYAN NOUBAR | BGMD | Stock Option (right to buy) | D | 7,78 | 4.205 | 4.205 | |||||
| 2012-02-29 | 2012-02-27 | 4 | BAINS HARRISON M JR | BGMD | Stock Option (right to buy) | D | 7,78 | 4.205 | 4.205 | |||||
| 2012-02-29 | 2012-02-27 | 4 | PAPADOPOULOS STELIOS | BGMD | Stock Option (right to buy) | D | 7,78 | 4.205 | 4.205 | |||||
| 2012-02-29 | 2012-02-27 | 4 | Harris Timothy J.R. | BGMD | Stock Option (right to buy) | D | 7,78 | 4.205 | 4.205 | |||||
| 2012-02-29 | 2012-02-27 | 4 | Bancel Stephane | BGMD | Stock Option (right to buy) | D | 7,78 | 4.205 | 4.205 | |||||
| 2012-02-24 | 2012-02-22 | 4 | ROGERS MICHAEL W | BGMD | Stock Option (right to buy) | D | 7,84 | 35.000 | 35.000 | |||||
| 2012-02-24 | 2012-02-22 | 4 | GORDON NEAL | BGMD | Stock Option (right to buy) | D | 7,84 | 30.000 | 30.000 | |||||
| 2012-02-24 | 2012-02-22 | 4 | Bancel Stephane | BGMD | Common Stock | D | 2.778 | 16.778 | ||||||
| 2012-02-24 | 2012-02-22 | 4 | Adourian Aram S. | BGMD | Stock Option (right to buy) | D | 7,84 | 40.000 | 40.000 | |||||
| 2012-02-24 | 2012-02-22 | 4 | Rader Anastasia | BGMD | Stock Option (right to buy) | D | 7,84 | 30.000 | 30.000 | |||||
| 2012-02-24 | 2012-02-22 | 4 | Miller Stephen R. | BGMD | Stock Option (right to buy) | D | 7,84 | 30.000 | 30.000 | |||||
| 2012-02-15 | 2012-02-13 | 4 | Posner Brian S | BGMD | Stock Option (right to buy) | D | 8,27 | 8.410 | 8.410 |
